The need for speed

Smart screening

Five in 100 are carriers

An estimated 5.2 percent of individuals worldwide carry a genetic mutation that causes thalassemia. Research indicates that 1.1 percent of couples worldwide are at risk of having children with a hemoglobin disorder, and that 2.7 children out of 1,000 conceptions are affected.

Ancestry and origin

Family history and geographic origin can be significant risk factors. Thalassemia primarily affects people with Mediterranean, South Asian, Southeast Asian, and Middle Eastern ancestry.

Carrier testing

Diagnostic DNA tests can identify the genetic mutation associated with thalassemia. Detection often takes place during pregnancy or soon after birth. Some countries offer routine screening for thalassemia to all pregnant women.

Tests can also be performed at any age to check for thalassemia or to see if an individual is a carrier.

Uniquely end-to-end

Our NGS solutions significantly reduce lab turnaround time and simplifies the clinical workflow for genetic testing of thalassemia in a single assay.

By eliminating the need for multiple parallel testing protocols, we have successfully replaced traditional methods with one test to meet growing laboratory demand for rapid, convenient screening.

Results in under five hours
The unique end-to-end procedure makes it possible to go from DNA to result in less than five hours, with under 45 minutes of handling time. Data analysis is swift and straightforward thanks to dedicated software.

The fast and simple NGS workflow is suitable for any lab, whether you are running advanced genetic testing or large-scale mutation screening.